85 results match your criteria: "Center of Expertise for Chronic Organ Failure[Affiliation]"
Expert Rev Respir Med
April 2019
b Department of Respiratory Medicine , Maastricht University Medical Center, Maastricht , The Netherlands.
Distinct pathologies can cause chronic obstructive pulmonary disease (COPD). Emphysema is a COPD-phenotype characterized by destruction of lung parenchyma. Alpha-1 antitrypsin deficiency (AATD) is a genetic cause of emphysema, whereas smoking is the most important risk factor of non-AATD emphysema.
View Article and Find Full Text PDFEur J Clin Nutr
November 2019
Department of Physiotherapy, Laboratory of Research in Respiratory Physiotherapy (LFIP), State University of Londrina, Londrina, Brazil.
Background/objectives: Abnormal body composition is an independent determinant of COPD outcomes. To date, it is already known that patient stratification into body composition phenotypes are associated with important outcomes, such as exercise capacity and inflammation, but there are no data comparing physical activity and muscle strength among these phenotypes. Thus, the aim of this study was to compare clinical characteristics and physical function in patients with COPD stratified into body composition phenotypes.
View Article and Find Full Text PDFJ Clin Med
December 2018
CIRO+, center of expertise for chronic organ failure, 6085 NM Horn, The Netherlands.
The degree of lung function is frequently used as referral criterion for pulmonary rehabilitation. The efficacy of pulmonary rehabilitation was assessed in 518 chronic obstructive pulmonary disease (COPD) patients, after clustering based on a comprehensive pre-rehabilitation lung function assessment. Mean improvements in dyspnea, exercise performance, health status, mood status and problematic activities of daily life after pulmonary rehabilitation were mostly comparable between the seven clusters, despite significant differences in the degree of lung function.
View Article and Find Full Text PDFERJ Open Res
October 2018
Dept of Research and Education, CIRO+, Center of Expertise for Chronic Organ Failure, Horn, The Netherlands.
http://ow.ly/2HER30mxLLj.
View Article and Find Full Text PDFRespiration
September 2019
Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
PLoS One
February 2019
CIRO+, center of expertise for chronic organ failure, Horn, The Netherlands.
Background: While spirometry and particularly airflow limitation is still considered as an important tool in therapeutic decision making, it poorly reflects the heterogeneity of respiratory impairment in chronic obstructive pulmonary disease (COPD). The aims of this study were to identify pathophysiological clusters in COPD based on an integrated set of standard lung function attributes and to investigate whether these clusters can predict patient-related outcomes and differ in clinical characteristics.
Methods: Clinically stable COPD patients referred for pulmonary rehabilitation underwent an integrated assessment including clinical characteristics, dyspnea score, exercise performance, mood and health status, and lung function measurements (post-bronchodilator spirometry, body plethysmography, diffusing capacity, mouth pressures and arterial blood gases).
J Am Med Dir Assoc
November 2018
Centre of Expertise in Palliative Care, Maastricht University Medical Centre, Maastricht, the Netherlands.
Objectives: Pain is a highly prevalent problem in older adults and dying patients. Opioids are the main analgesic for moderate to severe pain in these patients. Different properties of various opioids can make them more or less suitable for this specific population.
View Article and Find Full Text PDFAm J Respir Crit Care Med
February 2019
3 Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
Rationale: Bimagrumab is a fully human monoclonal antibody that blocks the activin type II receptors, preventing the activity of myostatin and other negative skeletal muscle regulators.
Objectives: To assess the effects of bimagrumab on skeletal muscle mass and function in patients with chronic obstructive pulmonary disease (COPD) and reduced skeletal muscle mass.
Methods: Sixty-seven patients with COPD (mean FEV, 1.
Arch Phys Med Rehabil
November 2018
Department of Research and Education, Center of Expertise for Chronic Organ Failure (CIRO), Horn, the Netherlands; Department of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands; COPD Center, Sahlgrenska University Hospital, Göteborg, Sweden.
Objective: To evaluate the effect of pulmonary rehabilitation (PR) on exercise performance and quality of life in patients with chronic obstructive pulmonary disease (COPD) with different degrees of static lung hyperinflation (LH).
Design: Retrospective cohort study.
Setting: PR network.
Nutr Clin Pract
April 2018
Department of Foods and Nutrition, University of Georgia, Athens, Georgia, USA.
Expert Rev Respir Med
May 2018
c Department of Research and Education , Center of Expertise for Chronic Organ Failure(CIRO), Horn , Netherlands.
Current pharmacologic therapy of chronic obstructive pulmonary disease (COPD) can reduce respiratory symptoms and exacerbation frequency. However, no single COPD intervention except for lung transplantation has proven effective in recovering lung function. Lung elasticity is reduced in COPD lungs, which is for a large part due to chronically enhanced elastin degradation.
View Article and Find Full Text PDFHeart Asia
August 2017
Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
Background: Heart failure (HF) may influence the lungs and vice versa. However, this interaction and the influence on right ventricular function (RVF) are insufficiently described in patients with HF divided into the recent groups based on left ventricular ejection fraction (LVEF): HF with reduced, midrange and preserved ejection fraction (HFrEF, HFmrEF and HFpEF, respectively).
Methods: Overall, 186 consecutive stable patients with HF seen in our outpatient clinic were retrospectively divided into HFrEF (n=70), HFmrEF (n=55) and HFpEF (n=61).
Eur Respir J
January 2018
Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Sarcoidosis Vasc Diffuse Lung Dis
March 2020
Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.
Patients with pulmonary fibrosis (PF) have a clear exercise intolerance. The 4-meter-gait-speed (4MGS) test and the 5-repetitions-sit-to-stand (5STS) test are easy, inexpensive and reliable measures of functional performance. Both tests have been validated in healthy adults and patients with chronic obstructive pulmonary disease.
View Article and Find Full Text PDFRespir Res
November 2017
Department of Pulmonary Medicine, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Cardiovascular diseases are prevalent in patients with chronic obstructive pulmonary disease (COPD). Their coexistence implies that many COPD patients require anticoagulation therapy. Although more and more replaced by direct oral anticoagulants, vitamin K antagonists (VKAs) are still widely used.
View Article and Find Full Text PDFBreathe (Sheff)
September 2017
Dept of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.
http://ow.ly/X2Pd30dCT7n.
View Article and Find Full Text PDFRespirology
October 2017
Faculty of Medicine and Life Sciences, Rehabilitation Research Centre, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Chron Respir Dis
May 2018
1 REVAL - Rehabilitation Research Center, BIOMED - Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
Chronic obstructive pulmonary disease (COPD) patients often experience lower limb muscle dysfunction and wasting. Exercise-based training has potential to improve muscle function and mass, but literature on this topic is extensive and heterogeneous including numerous interventions and outcome measures. This review uses a detailed systematic approach to investigate the effect of this wide range of exercise-based interventions on muscle function and mass.
View Article and Find Full Text PDFLancet Respir Med
July 2017
Department of Research and Education, CIRO+, Center of Expertise for Chronic Organ Failure, 6085 NM Horn, Netherlands; Department of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, Netherlands.
Respir Med
May 2017
Department of Research & Education, CIRO, Center of Expertise for Chronic Organ Failure, Horn, The Netherlands; Department of Respiratory Medicine, Maastricht University Medical Center+ (MUMC+), NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.
A more profound investigation about the responses in activity levels following pulmonary rehabilitation (PR) in patients with COPD is needed. We aimed to describe groups of patients with COPD according to patterns of change in physical activity and sedentary behaviour following PR. 90 patients with COPD (60% male; mean age 67 ± 8; median FEV 47 (32-62) %pred) completed a comprehensive PR programme.
View Article and Find Full Text PDFInt J Cardiol
August 2017
Department of Research & Education, CIRO, Center of Expertise for Chronic Organ Failure, Horn, The Netherlands.
Background: In-depth analyses of the measurement properties of the 6-minute walk test (6MWT) in patients with chronic heart failure (CHF) are lacking. We investigated the reliability, construct validity, and determinants of the distance covered in the 6MWT (6MWD) in CHF patients.
Methods: 337 patients were studied (median age 65years, 70% male, ejection fraction 35%).
Respirology
August 2017
Faculty of Medicine and Life Sciences, Rehabilitation Research Centre, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Background And Objective: This study aims to investigate the association between exercise tolerance, pulmonary function and lower-limb muscle function in patients with lung cancer who underwent lung resection surgery in the previous year.
Methods: Sixty-four patients (age: 67 ± 11 years, 66% males) performed a symptom-limited incremental cycle test to define peak oxygen consumption (VO peak) and peak workload (Wpeak). The best of two 6-min walking distance (6MWD) tests was also included.
Am J Respir Crit Care Med
March 2017
3 Department of Research and Education CIRO+, Center of Expertise for Chronic Organ Failure Horn, the Netherlands.
Neth Heart J
May 2017
Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
Background: Comorbidities are common in chronic heart failure (HF) patients, but diagnoses are often not based on objective testing. Chronic obstructive pulmonary disease (COPD) is an important comorbidity and often neglected because of shared symptoms and risk factors. Precise prevalence and consequences are not well known.
View Article and Find Full Text PDFSleep Med
February 2017
Academic Sleep Center, CIRO Center of Expertise for Chronic Organ Failure, Horn, The Netherlands. Electronic address:
Background: Obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) are independent risk factors for cardiovascular diseases. In patients with OSA and concurrent COPD, continuous positive airway pressure (CPAP) therapy improves survival. Nevertheless, a significant proportion of such patients do not tolerate CPAP.
View Article and Find Full Text PDF